131 related articles for article (PubMed ID: 11433951)
1. New leukemia drug receives FDA approval.
Mayo Clin Health Lett; 2001 Jul; 19(7):4. PubMed ID: 11433951
[No Abstract] [Full Text] [Related]
2. FDA approves Novartis' Gleevec.
Expert Rev Anticancer Ther; 2001 Jun; 1(1):3. PubMed ID: 12113126
[No Abstract] [Full Text] [Related]
3. Gleevec approved for first-line treatment of CML.
FDA Consum; 2003; 37(2):5. PubMed ID: 12715753
[No Abstract] [Full Text] [Related]
4. FDA approves Gleevec for pediatric leukemia.
FDA Consum; 2003; 37(4):6. PubMed ID: 12971334
[No Abstract] [Full Text] [Related]
5. New-age drug meets resistance.
McCormick F
Nature; 2001 Jul; 412(6844):281-2. PubMed ID: 11460142
[No Abstract] [Full Text] [Related]
6. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
Cohen MH; Williams G; Johnson JR; Duan J; Gobburu J; Rahman A; Benson K; Leighton J; Kim SK; Wood R; Rothmann M; Chen G; U KM; Staten AM; Pazdur R
Clin Cancer Res; 2002 May; 8(5):935-42. PubMed ID: 12006504
[TBL] [Abstract][Full Text] [Related]
7. A cancer 'smart bomb'. A new drug shows hope of conquering a form of leukemia by targeting the misbehaving cells.
Kalb C
Newsweek; 2000 Dec; 136(25):68. PubMed ID: 11126146
[No Abstract] [Full Text] [Related]
8. Quick success for cancer kinase treatment.
Nat Med; 2001 Jun; 7(6):637. PubMed ID: 11385473
[No Abstract] [Full Text] [Related]
9. FDA approves Gleevec for leukemia treatment.
FDA Consum; 2001; 35(4):6. PubMed ID: 11692893
[No Abstract] [Full Text] [Related]
10. Cancer's mechanics. Targeting errant cells.
Sobel RK
US News World Rep; 2001 May; 130(20):54. PubMed ID: 11383095
[No Abstract] [Full Text] [Related]
11. [Imatinib--en epoch-making new drug against chronic myeloid leukemia].
Lakartidningen; 2003 Jun; 100(26-27):2283. PubMed ID: 12872372
[No Abstract] [Full Text] [Related]
12. New leukemia drug shows promise against Gleevec resistance.
Ashraf H
Drug Discov Today; 2005 Apr; 10(7):453-4. PubMed ID: 15809187
[No Abstract] [Full Text] [Related]
13. Introduction: chronic myelogenous leukemia (CML).
Jabbour E; Kantarjian H
Semin Hematol; 2007 Jan; 44(1 Suppl 1):S1-3. PubMed ID: 17292735
[No Abstract] [Full Text] [Related]
14. [Attentive questions about treatment of chronic myelogenous leukemia with imatinib mesylate].
Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):433-5. PubMed ID: 17147242
[No Abstract] [Full Text] [Related]
15. Gleevec for the treatment of chronic myelogenous leukemia: US. Food and Drug Administration regulatory mechanisms, accelerated approval, and orphan drug status.
Cohen MH; Moses ML; Pazdur R
Oncologist; 2002; 7(5):390-2. PubMed ID: 12401900
[TBL] [Abstract][Full Text] [Related]
16. [Targeted therapy with imatinib has reformed the treatment of chronic myeloid leukemia].
Nielsen JL
Ugeskr Laeger; 2003 May; 165(20):2111. PubMed ID: 12812107
[No Abstract] [Full Text] [Related]
17. [Molecular therapy of chronic myeloid leukemia--a new era in the treatment of malignant diseases].
Deininger M; Niederwieser D
Med Klin (Munich); 2002 Jan; 97 Suppl 1():1. PubMed ID: 11831065
[No Abstract] [Full Text] [Related]
18. Update on the use of imatinib mesylate.
Sawyers CL
Clin Adv Hematol Oncol; 2005 Oct; 3(10):757-8. PubMed ID: 16258483
[No Abstract] [Full Text] [Related]
19. Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia.
Ossard-Receveur A; Bernheim A; Clausse B; Danglot G; Fauvet D; Leon B; Lozach F; Bories D; Brouzes C; Bourhis JH; Turhan AG
Cancer Genet Cytogenet; 2005 Dec; 163(2):189-90. PubMed ID: 16337868
[No Abstract] [Full Text] [Related]
20. Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.
Johnson JR; Bross P; Cohen M; Rothmann M; Chen G; Zajicek A; Gobburu J; Rahman A; Staten A; Pazdur R
Clin Cancer Res; 2003 Jun; 9(6):1972-9. PubMed ID: 12796358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
